C3 Glomerulopathy and post-infectious glomerulonephritis define a disease spectrum

Pediatric Nephrology

Volumn 31, Issue 11, 2016, Pages 2079-2086

  Al Ghaithi, Badria ^a   Chanchlani, Rahul ^a,b,c   Riedl, Magdalena ^d   Thorner, Paul ^a,e   Licht, Christoph ^a,d,f  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER CHILDREN S HOSPITAL   (Canada)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

C3 glomerulonephritis; C3 glomerulopathy; Complement alternative pathway; Dense deposit disease; Eculizumab; Post infectious glomerulonephritis

Indexed keywords

ADOLESCENT; ARTICLE; C3 GLOMERULOPATHY; CHILD; CLINICAL ARTICLE; COMPLEMENT ALTERNATIVE PATHWAY; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; MALE; POST INFECTIOUS GLOMERULONEPHRITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; SCHOOL CHILD; STEROID THERAPY; BIOPSY; BLOOD; COMMUNICABLE DISEASE; COMPARATIVE STUDY; COMPLICATION; GLOMERULUS; LONGITUDINAL STUDY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; METABOLISM; PATHOLOGY; URINE;

COMPLEMENT COMPONENT C3;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; COMPLEMENT C3; COMPLEMENT PATHWAY, ALTERNATIVE; FEMALE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; KIDNEY GLOMERULUS; LONGITUDINAL STUDIES; MALE; PROTEINURIA;

EID: 84961855323     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-015-3311-3     Document Type: Article

References (16)

1. Eison TM, Ault BH, Jones DP, Chesney RW, Wyatt RJ (2011) Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis. Pediatr Nephrol 26:165–180
2. Nadasdy T, Hebert LA (2011) Infection-related glomerulonephritis: understanding mechanisms. Semin Nephrol 31:369–375
3. Montseny JJ, Meyrier A, Kleinknecht D, Callard P (1995) The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature. Medicine (Baltimore) 74:63–73
4. Fakhouri F, Fremeaux-Bacchi V, Noel LH, Cook HT, Pickering MC (2010) C3 glomerulopathy: a new classification. Nat Rev Nephrol 6:494–499
5. Pickering MC, D’Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, Alpers CE, Bajema IM, Bedrosian C, Braun M, Doyle M, Fakhouri F, Fervenza FC, Fogo AB, Fremeaux-Bacchi V, Gale DP, Goicoechea de Jorge E, Griffin G, Harris CL, Holers VM, Johnson S, Lavin PJ, Medjeral-Thomas N, Paul Morgan B, Nast CC, Noel LH, Peters DK, Rodriguez de Cordoba S, Servais A, Sethi S, Song WC, Tamburini P, Thurman JM, Zavros M, Cook HT (2013) C3 glomerulopathy: consensus report. Kidney Int 84:1079–1089
6. Servais A, Noel LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grunfeld JP, Niaudet P, Lesavre P, Fremeaux-Bacchi V (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82:454–464
7. McCaughan JA, O’Rourke DM, Courtney AE (2012) Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies. Am J Transplant 12:1046–1051
8. Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D’Agati VD, Canetta PA, Radhakrishnan J, Appel GB (2012) Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol 7:748–756
9. Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa N, Nasr SH, Smith RJ (2013) Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 83:293–299
10. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263
11. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637
12. Rodriguez-Iturbe B, Musser JM (2008) The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol 19:1855–1864
13. Fremeaux-Bacchi V, Weiss L, Demouchy C, May A, Palomera S, Kazatchkine MD (1994) Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity. Nephrol Dial Transplant 9:1747–1750
14. Meri S (1985) Complement activation by circulating serum factors in human glomerulonephritis. Clin Exp Immunol 59:276–284
15. Habbig S, Mihatsch MJ, Heinen S, Beck B, Emmel M, Skerka C, Kirschfink M, Hoppe B, Zipfel PF, Licht C (2009) C3 deposition glomerulopathy due to a functional factor H defect. Kidney Int 75:1230–1234
16. Radhakrishnan S, Lunn A, Kirschfink M, Thorner P, Hebert D, Langlois V, Pluthero F, Licht C (2012) Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med 366:1165–1166